Koninklijke Philips Stock (NYSE:PHG)
Previous Close
$25.96
52W Range
$19.49 - $32.91
50D Avg
$30.30
200D Avg
$25.91
Market Cap
$24.25B
Avg Vol (3M)
$818.55K
Beta
0.79
Div Yield
$0.92 (3.74%)
PHG Company Profile
Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; and male grooming and beauty products and solutions. It has a strategic collaboration with Ibex Medical Analytics Ltd. to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide, as well as a strategic partnership agreement with NICO.LAB. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
PHG Performance
Revenue Breakdown
Revenue Breakdown by Product/Service
Product/Service | Dec 22 | Dec 21 | Dec 20 |
---|---|---|---|
China | €2.19B | €2.33B | €2.43B |
Japan | €1.08B | €1.07B | €1.31B |
United Kingdom of Great Britain and Northern Ireland | €463.00M | €481.00M | - |
Netherlands | €540.00M | €570.00M | €555.00M |
Germany | €821.00M | €839.00M | €1.11B |
France | €400.00M | €397.00M | €545.00M |
Other countries | €5.08B | €5.04B | €6.43B |
United States of America | €7.25B | €6.42B | €6.64B |
Korea (Republic of) | - | - | €509.00M |
Peer Comparison
Ticker | Company |
---|---|
ZBH | Zimmer Biomet Holdings, Inc. |
ABT | Abbott Laboratories |
BRKR | Bruker Corporation |
ITGR | Integer Holdings Corporation |
PODD | Insulet Corporation |
SYK | Stryker Corporation |
ZIMV | ZimVie Inc. |
EW | Edwards Lifesciences Corporation |
MDT | Medtronic plc |
STE | STERIS plc |
GMED | Globus Medical, Inc. |
GKOS | Glaukos Corporation |
NVCR | NovoCure Limited |
NARI | Inari Medical, Inc. |
SNN | Smith & Nephew plc |
BIO | Bio-Rad Laboratories, Inc. |
INSP | Inspire Medical Systems, Inc. |
CNMD | CONMED Corporation |